Atlas Trials

Intravesical Administration of rAd-IFN/Syn3 in Patients With BCG-Refractory or Relapsed Bladder Cancer

Clinical trial NCT01687244 · COMPLETED

Trial details

NCT number
NCT01687244
Sponsor
FKD Therapies Oy
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Superficial Bladder Cancer
Start date
2012-09-01
Primary completion
2015-10-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.